Navigation Links
BioWorld Launches Enhanced Website
Date:11/2/2011

ATLANTA, Nov. 2, 2011 /PRNewswire-USNewswire/ -- Biopharmaceutical industry insiders know that news about the world's most innovative drugs in development has always come from BioWorld. BioWorld's award-winning coverage of the biopharma industry continues, but now it's bigger, better and has more with a brand new website (www.bioworld.com).

It's easier than ever to access BioWorld Today, BioWorld Insight and BioWorld International. A brand new turbo-charged search engine facilitates more precise searches for a database that's rich with more than two decades of data on drugs in development, the companies behind those drugs, key scientific milestones, the deals, regulatory hurdles, financings and analysis.

"We've spent a lot of time and resources internally working on the site. But our focus has always been to the outside – on enhancing our content and the overall experience for our customers," said Donald R. Johnston, BioWorld's senior vice president and group publisher. "We hope both subscribers and first-time visitors spend some time exploring all of the new site's assets. We look forward to your feedback!"  

Other enhancements include:

  • Breaking news stories from around the globe presented up front, as they happen.
  • Thought leaders weigh in via BioWorld Perspectives, a blog for the biopharma community.
  • An instant poll provides feedback on hot topics.
  • One-click access to the biopharma social community on Twitter, LinkedIn and Facebook.
  • Key industry players sound off in BioWorld videos.
  • A deeper dive beyond breaking news with industry analysis from BioWorld Insight.
  • Video, images, content sharing with social media and comments

Biotech news junkies have a reason to make BioWorld.com their home page. Visit in the morning to get a daily biopharmaceutical news fix. Then stay for breaking news as it happens plus analysis, opinion and so much more.

#bioworldfreeday
Though anyone can tour the site now, non-subscribers have limited access to content. BioWorld is planning a free, open-access day in the very near future. Follow  #bioworldfreeday to find out when.

About BioWorld®
BioWorld Today (www.bioworld.com) delivers actionable intelligence on the biotech science that drives the business, which funds the means to heal disease. With writers and editors stationed around the globe, BioWorld Today reports the breaking news and provides key perspective on hundreds of medicines in development, the companies behind those therapeutic candidates, the business development transactions that evolve the market, and the regulatory hurdles that both challenge and guard the process.


'/>"/>
SOURCE BioWorld
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmunGenes Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today
2. joimax® Launches Numerous Innovations at NASS Chicago From November 2 - 4, 2011
3. Advanced Biologics Launches OsteoAMP® Structural at the 26th Annual Meeting of the North American Spine Society
4. Life Spine Awarded Seven New Patents, Launches Six New Product Lines & Realizes 25% Sales Growth
5. Azantis Launches Liposomal Glutathione and Vitamin C.
6. Australias Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elektas Advanced 4D Motion Management Technology
7. Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector
8. FHSSA Launches New Campaign to Partner US Hospices with Programs in Sub-Saharan Africa
9. nContact, Inc. Launches New Corporate Websites
10. First Response Launches IVF Fundraising Resource for Those Trying for a Baby
11. CDC Launches Effort to Protect Cancer Patients From Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology:
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):